Researchers develop vaccine to fight opioid misuse, addiction

Immunizations for the flu, smallpox and polio are essential in protecting against dangerous diseases. Now, widespread opioid addiction has pushed researchers to develop a vaccine against the effects of overdose and misuse.

According to results presented at the National Meeting & Exposition of the American Chemical Society (ACS), researchers are developing a vaccine against the growing threat of opioid addiction. The vaccine was developed to prevent opioid receptors in the body from attaching to antibodies, a method that involved the linking together of the opioid molecules which are normally too small to block.

"There is an urgent need to discover effective medications to treat substance use disorders. Increasingly, drug users are turning to opioids and powerful synthetic versions of these drugs that can sometimes be as much as 100 times more potent than heroin," said Kim D. Janda, PhD, head of the vaccine research team.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup